David Ridley, PhD, is the Faculty Director of the Health Sector Management program at Duke University’s Fuqua School of Business. In his research, David examines innovation and pricing, especially in health care. To encourage innovation in medicines for neglected diseases, David, with Jeffrey Moe and Henry Grabowski, proposed a priority review voucher prize. The voucher program became law in 2007.

Recent Posts by David B. Ridley

The Regulatory Burden Of The Priority Review Voucher Program

Recently an official from the Food and Drug Administration (FDA) expressed concern about the costs to the FDA of the priority review voucher program. But it doesn’t have to be that way, and it’s important to tackle these concerns.